Literature DB >> 2734021

Activation of the ret-II oncogene without a sequence encoding a transmembrane domain and transforming activity of two ret-II oncogene products differing in carboxy-termini due to alternative splicing.

Y Ishizaka1, M Ochiai, T Tahira, T Sugimura, M Nagao.   

Abstract

We previously reported the cloning of a transforming gene, ret-II, which contains the proto-ret kinase domain. In the present study ret-II cDNAs were cloned from a transformant and analyzed. The restriction map and nucleotide sequence indicated that the sequence upstream of the proto-ret kinase domain was replaced by another sequence, which encoded a fusion protein composed of 899 amino acids. This non-proto-ret sequence differed from that of the ret previously reported and had no hydrophobic amino acid stretch for a transmembrane domain. Furthermore, we obtained two kinds of ret-II cDNAs differing in their 3' regions and found that the differences were generated by alternative splicing. From these cDNAs, two types of oncogene products differing in their carboxy-terminal amino acid residues were predicted. The two products exhibited similar transforming activity in NIH3T3 cells. These data indicate that activation of proto-ret can occur as a result of replacement of the extra-cellular and transmembrane domains with the hydrophilic sequence. In addition, differences in the carboxy-terminal amino acid residues in the two types of ret-II oncogene products have no influence on the transforming activity of the ret-II oncogene.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2734021

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  The many faces of RET dysfunction in kidney.

Authors:  Sanjay Jain
Journal:  Organogenesis       Date:  2009-10       Impact factor: 2.500

2.  Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis.

Authors:  Yang Du; Sally E Spence; Nancy A Jenkins; Neal G Copeland
Journal:  Blood       Date:  2005-06-16       Impact factor: 22.113

3.  Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A.

Authors:  I Bongarzone; N Monzini; M G Borrello; C Carcano; G Ferraresi; E Arighi; P Mondellini; G Della Porta; M A Pierotti
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

4.  Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

Authors:  M Santoro; F Carlomagno; I D Hay; M A Herrmann; M Grieco; R Melillo; M A Pierotti; I Bongarzone; G Della Porta; N Berger
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

5.  Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC.

Authors:  M A Pierotti; M Santoro; R B Jenkins; G Sozzi; I Bongarzone; M Grieco; N Monzini; M Miozzo; M A Herrmann; A Fusco
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

6.  Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase.

Authors:  G A Rodrigues; M Park
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

7.  An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway.

Authors:  M Santoro; W T Wong; P Aroca; E Santos; B Matoskova; M Grieco; A Fusco; P P di Fiore
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

Review 8.  Mutation Profile of Well-Differentiated Thyroid Cancer in Asians.

Authors:  Young Shin Song; Jung Ah Lim; Young Joo Park
Journal:  Endocrinol Metab (Seoul)       Date:  2015-09

9.  Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene.

Authors:  T Iwamoto; M Takahashi; M Ito; K Hamatani; M Ohbayashi; W Wajjwalku; K Isobe; I Nakashima
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

10.  Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours.

Authors:  M Santoro; N Sabino; Y Ishizaka; T Ushijima; F Carlomagno; A Cerrato; M Grieco; C Battaglia; M L Martelli; C Paulin
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.